Socioeconomic Burden Of Major Rheumatic Diseases In A Tertiary Care Facility: Socioeconomic Burden of Major Rheumatic Diseases

Muhammad  Sharif; Muhammad  Sufyan Khan; Tayyeba  Khursheed Ahmed; Somaya  Shah; Saira  Tahir; Avinash  Punshi

doi:10.54393/pbmj.v5i6.575

Authors

Muhammad Sharif PGR Rheumatology Department PIMS, Islamabad
Muhammad Sufyan Khan PGR Rheumatology Department PIMS, Islamabad
Tayyeba Khursheed Ahmed PGR Rheumatology Department PIMS, Islamabad
Somaya Shah PGR Rheumatology Department PIMS, Islamabad
Saira Tahir PGR Rheumatology Department PIMS, Islamabad
Avinash Punshi PGR Rheumatology Department PIMS, Islamabad

DOI:

https://doi.org/10.54393/pbmj.v5i6.575

Keywords:

SES, Rheumatoid Arthritis, Rheumatic diseases, Musculoskeletal

Abstract

Rheumatic diseases can have serious socioeconomic implications in a developing country like Pakistan. With dwindling resources in the healthcare sector, decision makers are forced to prioritize treatment between patients. Objective: To assess the socio-economic burden of major rheumatic diseases in a tertiary care hospital. Methods:171 patients were enrolled in the study prospectively. Patients were selected through specially designed questionnaires. Diagnosis of the disease and patient’s socioeconomic status were recorded and analyzed using SPSS version 25.0. Results: The mean age of the participants was 38.65±13.20 years. A higher ratio of female patients (78.4 %) as compared to the male patients (21.6 %) was seen. The majority of the patients were not well educated as 79 % of the patients were below matric, 9 patients were graduated and only 2 patients were postgraduates. Most of patient fall in low socioeconomic background (30,924.8 ± 19,107.3). Out of all the rheumatic diseases, Rheumatoid Arthritis 96 (56.1 %)was the most commonly found autoimmune disease. Conclusion: Rheumatic disease outcomes in Pakistan are influenced significantly by socioeconomic status. A comprehensive treatment plan for rheumatic disease is needed, especially for those with low education levels and poor quality of life.

References

Kuijpers T, van der Windt DA, van der Heijden GJ, Twisk JW, Vergouwe Y, Bouter LM. A prediction rule for shoulder pain related sick leave: a prospective cohort study. BMC Musculoskeletal Disorders. 2006 Dec; 7:97. doi: 10.1186/1471-2474-7-97.

Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research. 2018 Apr; 6:15. doi: 10.1038/s41413-018-0016-9.

Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. British journal of rheumatology.1998 May; 37(5):491-5. doi: 10.1093/rheumatology/37.5.491.

Imran MY, Saira Khan EA, Ahmad NM, Farman Raja S, Saeed MA, Ijaz Haider I. Depression in Rheumatoid Arthritis and its relation to disease activity. Pakistan Journal of Medical Sciences. 2015 Mar-Apr; 31(2):393-7.

Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2000 Jan; 39(1):28-33. doi: 10.1093/rheumatology/39.1.28.

Rice DP. Estimating the cost of illness. Am J Public Health Nations Health. 1967 Mar;57(3):424-40. doi: 10.2105/ajph.57.3.424.

Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011 Aug; 29(8):653-71. doi: 10.2165/11588380-000000000-00000.

Cruz-Castillo Y, Montero N, Salazar-Ponce R, Villacís-Tamayo R. Quality of Life in Ecuadorian Patients with Rheumatoid Arthritis: A Cross-sectional Study. Reumatología Clínica (Engl Ed). 2019 Sep-Oct; 15(5):296-300. English, Spanish. doi: 10.1016/j.reuma.2017.08.012.

Russell O, Lester MS, Black R, Hill C. Socioeconomic status (ses) and medication use in rheumatoid arthritis (ra): a scoping review. In Internal Medicine Journal 2020; 50:20-23.

Chen HH, Lin CH, Wang CY, Chao WC. Association of Hospitalised Infection with Socioeconomic Status in Patients with Rheumatoid Arthritis Receiving Biologics or Tofacitinib: A Population-Based Cohort Study. Frontiers in Medicine (Lausanne). 2021 Jul 12; 8:696167. doi: 10.3389/fmed.2021.696167.

Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F, et. al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. Journal of Rheumatology. 2005;32(2):348-53.

Yang DH, Huang JY, Chiou JY, Wei JC. Analysis of Socioeconomic Status in the Patients with Rheumatoid Arthritis. International journal of environmental research and public health. 2018 Jun 7;15(6):1194. doi: 10.3390/ijerph15061194.

Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, et al. Association of Stress-Related Disorders with Subsequent Autoimmune Disease. JAMA. 2018 Jun 19;319(23):2388-2400. doi: 10.1001/jama.2018.7028.

Harrison SR, Li D, Jeffery LE, Raza K, Hewison M. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcified tissue international.2020 Jan; 106(1):58-75. doi: 10.1007/s00223-019-00577-2.

http://mecometer.com/compare/pakistan+united-states/vehicles-per-thousand-people/

Cuijpers P, Ebert DD, Acarturk C, Andersson G, Cristea IA. Personalized psychotherapy for adult depression: a meta-analytic review. Behavior Therapy. 2016 Nov; 47(6): 966-80.doi.org/10.1016/j.beth.2016.04.007

Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG. Treatment of rheumatoid arthritis: unraveling the conundrum. Journal of autoimmunity. 2015 Dec; 65:1-8. doi.org/10.1016/j.jaut.2015.10.003

Filipovic I, Walker D, Forster F, Curry AS. Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology. 2011 Jun; 50(6):1083-90. doi.org/10.1093/rheumatology/keq399

Zhang W, Anis AH. The economic burden of rheumatoid arthritis: beyond health care costs. Clinical rheumatology. 2011 Mar; 30(1):25-32. doi.org/10.1007/s10067-010-1637-6

Furneri G, Mantovani LG, Belisari A, Mosca M, Cristiani M, Bellelli S, et al. Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clinical and Experimental Rheumatology-Incl Supplements. 2012 Jul; 30(4): S72.